Formulation for treating candidiasis using Morinda citrifolia

Details Formulation for treating candidiasis using Morinda citrifolia Formulation for treating candidiasis using Morinda citrifolia

2006-01-26

2008-10-28

Leith, Patricia (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Containing or obtained from a fruit , including berry

C424S725000

Reexamination Certificate

active

07442395

ABSTRACT:
The present invention features a formulation from the Indian mulberry plant (Morinda citrifolia) comprisingMorinda citrifoliafruit juice,Morinda citrifoliaoil, quercetin,Morinda citrifoliapuree juice andMorinda citrifoliadietary fiber treating Candidiasis.

REFERENCES:
patent: 4039559 (1977-08-01), Nakamura
patent: 4409144 (1983-10-01), Heinicke
patent: 4463025 (1984-07-01), Strobel
patent: 4543212 (1985-09-01), Heinicke
patent: 4666606 (1987-05-01), Heinicke et al.
patent: 4793991 (1988-12-01), Slimak
patent: 4948785 (1990-08-01), Nguyen
patent: 4996051 (1991-02-01), Meer et al.
patent: 5106634 (1992-04-01), Thacker et al.
patent: 5110803 (1992-05-01), Nguyen
patent: 5213836 (1993-05-01), McGillivray et al.
patent: 5268467 (1993-12-01), Verbiscar
patent: 5275834 (1994-01-01), Thibault et al.
patent: 5288491 (1994-02-01), Moniz
patent: 5431927 (1995-07-01), Hand et al.
patent: 5472699 (1995-12-01), Duffy et al.
patent: 5503825 (1996-04-01), Lane
patent: 5595756 (1997-01-01), Bally et al.
patent: 5616569 (1997-04-01), Reinhart
patent: 5717860 (1998-02-01), Graber et al.
patent: 5725875 (1998-03-01), Noll et al.
patent: 5736174 (1998-04-01), Cooper et al.
patent: 5744187 (1998-04-01), Gaynor
patent: 5770217 (1998-06-01), Kutilek, III et al.
patent: 5776441 (1998-07-01), Scancarella et al.
patent: 5843499 (1998-12-01), Moreau et al.
patent: 5851573 (1998-12-01), Lepine et al.
patent: 5922766 (1999-07-01), Acosta et al.
patent: 5961998 (1999-10-01), Arnaud et al.
patent: 5962043 (1999-10-01), Jones et al.
patent: 5976549 (1999-11-01), Lewandowski
patent: 6029141 (2000-02-01), Bezos et al.
patent: 6039952 (2000-03-01), Sunvold et al.
patent: 6086859 (2000-07-01), Calello et al.
patent: 6086910 (2000-07-01), Howard et al.
patent: 6133323 (2000-10-01), Hayek
patent: 6136301 (2000-10-01), Pelle et al.
patent: 6139897 (2000-10-01), Goto et al.
patent: 6156355 (2000-12-01), Shields, Jr. et al.
patent: 6214351 (2001-04-01), Wadsworth et al.
patent: 6254913 (2001-07-01), Wadsworth et al.
patent: 6261566 (2001-07-01), Pillai et al.
patent: 6280751 (2001-08-01), Fletcher et al.
patent: 6291533 (2001-09-01), Fleischner
patent: 6299925 (2001-10-01), Xiong et al.
patent: 6387370 (2002-05-01), Yegorva
patent: 6405948 (2002-06-01), Hahn et al.
patent: 6417157 (2002-07-01), Wadsworth et al.
patent: 6436449 (2002-08-01), Gidlund
patent: 6477509 (2002-11-01), Hammons et al.
patent: 6528106 (2003-03-01), Wadsworth et al.
patent: 6589514 (2003-07-01), Jensen et al.
patent: 6737089 (2004-05-01), Wadsworth et al.
patent: 6749875 (2004-06-01), Selleck
patent: 6855345 (2005-02-01), Jensen et al.
patent: 6855354 (2005-02-01), Jensen et al.
patent: 7014873 (2006-03-01), West et al.
patent: 7018662 (2006-03-01), Jensen et al.
patent: 7048952 (2006-05-01), Gerson et al.
patent: 2001/0033871 (2001-10-01), Gidlund
patent: 2002/0068102 (2002-06-01), Su et al.
patent: 2002/0090406 (2002-07-01), Su et al.
patent: 2002/0147643 (2002-10-01), Olsen et al.
patent: 2002/0187168 (2002-12-01), Jensen et al.
patent: 2003/0060405 (2003-03-01), Klieiman et al.
patent: 2003/0086989 (2003-05-01), Jensen et al.
patent: 2003/0086990 (2003-05-01), Wang et al.
patent: 2003/0108629 (2003-06-01), Chou
patent: 2003/0108630 (2003-06-01), Story et al.
patent: 2003/0108631 (2003-06-01), Jensen et al.
patent: 2003/0134001 (2003-07-01), Jensen et al.
patent: 2003/0134002 (2003-07-01), Jensen et al.
patent: 2003/0206895 (2003-11-01), Cavazza
patent: 2003/0225005 (2003-12-01), Gerson et al.
patent: 2004/0258780 (2004-12-01), Woltering et al.
patent: 11-43442 (1989-10-01), None
patent: 88/05304 (1988-07-01), None
patent: 01/15551 (2001-03-01), None
patent: 01/15553 (2001-03-01), None
patent: 01/64231 (2001-09-01), None
patent: 02/45654 (2002-06-01), None
patent: 02/45734 (2002-06-01), None
Starbuck, J.D. Elderberry & Cat's Claw; Better Nutrition; Sep. 1998; 60, 9, pp. 54, 55, 56 & 58.
Product Alert: Tahiti Trader's Noni Juice—Ready to Drink Coctail; High Potency Dietary Supplement; Jun. 2000, vol. 30, No. 11, one page.
Drug Development; The Pain Killer Tree: An Ancient Remedy Rediscovered; Pain & Central Nervous System Week, Nov. 2001pp. 1-2.
Rosenfeld, M Tropical Noni, A Tonic Boom; Nasty-Tasting Fruit Rockets Onto the Health Product Market; The Washington Post, Aug. 1997, p. C01 (pp. 1-4 of ProQuest).
Drug Development; The Pain Killer Tree: An Ancient Remedy Rediscovered; Pain & central Nervous System Week; Atlanta, Nov. 19, 2001; p. 19 (pp. 1-2 of ProQuest).
Daulataba et al., “Ricinoleic acid inMorinda citrifoliaseed oil,” J. Oil Tech. Assoc. India (Mumbai, India) 21(2):26-27 (1989).
Dittmar, Morinda, “Use in Indigenous Samoan Medicine,” J. of Herbs, Spices & Medicinal Plants, 1(3):77-92 (1993).
El-Gammal et al., “Antimicrobial Activities of Some Flavonoid Compounds,” Microbiol. 141:561-565 (1986).
Elkins, Hawaiian Noni, Woodland Publishing, pp. 6-31 (1998).
Farine et al., Volatile Components of Ripe Fruits of??.
Fisher, Living Better, V 1(5).
Gagnon, D., “Liquid Herbal Drops in Everyday Use,” 3d Ed., Bot. Res. Ed. Inst., p. 27 (1997)
Gura, “Systems for Identifying New Drugs are Ofter Faulty,” Science 278:1041-1042 (1997).
Hawegawa et al., “Anti-Helicobacter Pylor; Medicine Containing Extract of Dried Root ofMorinda citrifolia,” Abstract (1996).
Hirazumi et al.,“An Immunomodulatory Polysaccharide-Rich Substance from the Fruit Juice ofMorina citrifolia(Noni)withAntitumorActivity,”Phytotherapy Research, 13:380-387(1999).
Holleran, “The Zotics Splash, Beverage Industry,” 91(6) (2000).
Lampur, “Morinda achieves phenomenal sales of Tahitian noni juice”, Malaysian Nat. News Agency Jul. 1999, p. 1.
Kimstra et al., “Foods of the Key deer,” FL Sci., 53(4):264-273 (1990).
Lane, “The Merck Manual,” 17th Ed., pp. 449-451 (1999) *** Need Copy.
Levand et al., “Some chemical constituents ofMorinda citrifolia,” Planta Medica 36(2):186-187 (1979).
Liu et al,2 Novel GlycosidesfromtheFruitsofMorindaCitrifolia (Noni) Inhibit AP-1 Transactivation&CellTransformationintheMouseEpidermalJB6CellLine, Cancer Res.61:5749-5756(2001.
Morona et al., “Pharmacological properties of some aminoalkanolic derivatives of xanthone,” Pharmazie 56:567-572 (2001).
Morton, “The ocean-going noni, or Indian mulberry (Morinda citrifolia) and some of its ‘colorful’ relatives,” Econ. Bot., 46(3):241-256 (192).
Mueller et al., “Noni Juice (Morinda Citrifolia): Hidden Potential for Hyperkalameia?” Am H. Kidney Diseases.
Mumford, L., “Benefits of Noni Juice may be Imagined; $30 Price Tag Isn't”, So. Bend Tribune, So. Bend, Ind., pp. 1-2 (1998).
Naito, “Trace components in mulberry leaves,” Nippon Nogei Kagaku Kaishi 42(7):423-425 (1968).
Peres et al., “Tetraoxygenated naturally occurring xanthones,” Phytochemestry 55:683-710 (2000).
Product Alert. Oct. 11, 1999 29(19) PROMT Abstract.
Product Alert. Dec. 27, 1999 (29(24) PROMT Abstract.
Product Alert. Jun. 12, 2000 30(11) PROMT Abstract.
Rosenfelt, “Tropical Noni, a Tonic Boom; Nasty-Tasting Fruit Rockets onto the Health Product Market,” Wash. Post; Aug. 7, 1997, p. C01:1-4 of Proquest.
Sang et al., “Chemical Components in Noni Fruits and Leaves (Morinda citrifoliaL.); Quality Management of Nutraceuticals,”Proceedings of Symposium,ACS,Wash.,DC pp. 134-150(2002.
Sang et al., “Flavonal Glycosides and Novel Irdoid Glycoside from the Leaves ofMorinda citrifolia,” J. Agric.
“Rachel Perry Environmental Skin Protector SPF 18,” Product Alert, V.29(2) (1999).
Tahitian Noni Products (http://www.noni-now.com) (1998-2003).
Termumo Copr., “Anti-helicobacter pylon agent confic. Extract of dried roots ofMorinda citrifolia. . . ” Database DWPI on West, An. 1996-439483 JP 08-217686-Japan (Aug. 1996).
Wang et al., J. Agric. Food Chem. 47(12):4880-7882 (1999).
Wang, Mingfu., “Chemica

Affiliated with

Also associated with

Rating

Formulation for treating candidiasis using Morinda citrifolia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for treating candidiasis using Morinda citrifolia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for treating candidiasis using Morinda citrifolia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4001773